Google News – Clinical Trials External News
Regulatory & Compliance Articles
Google News – FDA (biotech/pharma) External News
Jemperli accepted for priority review by US FDA - PharmaTimes
Industry News External News
New private not-for-profit hospital planned for eastern Singapore as demand for beds remains high - AsiaOne
Google News – FDA (biotech/pharma) External News
Aurobindo Pharma Shares Rise After US FDA Inspection Update - Equitypandit
Google News – FDA (biotech/pharma) External News
Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard' - pharma.economictimes.indiatimes.com
Google News – FDA (biotech/pharma) External News
US FDA approves Takeda, Protagonist's drug for rare blood cancer - pharma.economictimes.indiatimes.com
Google News – Pharmaceuticals External News
Will Japan’s First IMCIVREE Approval in Hypothalamic Obesity Change Rhythm Pharmaceuticals’ (RYTM) Narrative - simplywall.st
Google News – FDA (biotech/pharma) External News
FDA approves Protagonist and Takeda’s drug for rare blood cancer - STAT
Google News – Pharmaceuticals External News
Jazz Pharmaceuticals (JAZZ) Could Be 13% Undervalued On FDA Approval Of Ziihera - simplywall.st
Google News – EMA (biotech/pharma) External News
EMA Flags Schizophrenia Drug Paliperidone Shortage in EU States Over Pharmathen Manufacturing Issues - Medical Dialogues
Google News – Pharmaceuticals External News
BlackRock Inc. Makes New Investment in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Google News – Clinical Trials External News
Lecanemab’s At-Home Start Dose Just Rewrote the Rules for Alzheimer’s Trial Design - The Clinical Trial Vanguard
Google News – Clinical Trials External News
Busy FDA Week, Framework to Guide CMT Clinical Trials, Mentorship and the Future of Brain Injury Medicine - NeurologyLive
Google News – FDA (biotech/pharma) External News
Takeda receives US FDA approval of Mimrylo - The Pharma Letter
Google News – FDA (biotech/pharma) External News